2020
DOI: 10.1016/j.anl.2020.03.013
|View full text |Cite
|
Sign up to set email alerts
|

Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 41 publications
0
8
0
Order By: Relevance
“…NRP2 has also been found to be closely associated with metastasis and BRAFV600E in thyroid cancer [54]. Downregulation of NRP2 has been shown to influence epithelial-mesenchymal transition by affecting phosphorylation signaling pathways [54]. This suggests a potential association of NRP2 expression with the TME and gene mutations.…”
Section: Biomed Research Internationalmentioning
confidence: 99%
“…NRP2 has also been found to be closely associated with metastasis and BRAFV600E in thyroid cancer [54]. Downregulation of NRP2 has been shown to influence epithelial-mesenchymal transition by affecting phosphorylation signaling pathways [54]. This suggests a potential association of NRP2 expression with the TME and gene mutations.…”
Section: Biomed Research Internationalmentioning
confidence: 99%
“…NRP2 expression has been associated both with increased proliferation rate as well as with the capability of tumor cells to escape from programmed cell death in cancer cells ( 13 , 50 , 51 ). We observed decreased cell viability in NRP2 knockdown cells, but further studies are needed to clarify whether this is a consequence of lower proliferation rate or increased cell death.…”
Section: Discussionmentioning
confidence: 99%
“…In previous studies, the cellular functions of NRP2 have been disclosed in various cancers. For example, in papillary thyroid cancer, NRP2 could promote cell growth and is closely associated with extrathyroid extension and lymph node metastasis [ 34 ]. It was also reported that NRP2 could act as an independent prognostic factor for prostate adenocarcinoma patients, as its upregulation was correlated with the worse outcome of patients [ 35 ].…”
Section: Discussionmentioning
confidence: 99%